| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.11 | 0.04 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.085 | 0.07 |
| mRNA | paclitaxel | CCLE | pan-cancer | AAC | -0.077 | 0.09 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.053 | 0.3 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.045 | 0.3 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.036 | 0.4 |